Swiss National Bank
DGX icon

Swiss National Bank’s Quest Diagnostics DGX Stock Holding History

Swiss National Bank’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7M Sell
309,900
-16,600
-5% -$3.26M 0.03% 383
2026
Q1 		$64M Buy
326,500
+20,000
+7% +$3.89M 0.04% 378
2025
Q4 		$53.2M Sell
306,500
-15,300
-5% -$2.79M 0.03% 413
2025
Q3 		$61.3M Sell
321,800
-16,100
-5% -$2.86M 0.04% 377
2025
Q2 		$60.7M Buy
337,900
+23,100
+7% +$4.01M 0.04% 383
2025
Q1 		$53.3M Buy
314,800
+400
+0.1% +$65.7K 0.04% 385
2024
Q4 		$47.4M Sell
314,400
-15,400
-5% -$2.4M 0.03% 423
2024
Q3 		$51.2M Buy
329,800
+2,100
+0.6% +$314K 0.03% 428
2024
Q2 		$44.9M Sell
327,700
-9,000
-3% -$1.23M 0.03% 440
2024
Q1 		$44.8M Sell
336,700
-14,300
-4% -$1.86M 0.03% 457
2023
Q4 		$48.4M Sell
351,000
-9,300
-3% -$1.22M 0.04% 425
2023
Q3 		$43.9M Sell
360,300
-43,700
-11% -$5.82M 0.03% 431
2023
Q2 		$56.8M Sell
404,000
-48,000
-11% -$6.62M 0.04% 412
2023
Q1 		$63.9M Sell
452,000
-22,200
-5% -$3.18M 0.04% 383
2022
Q4 		$74.2M Sell
474,200
-34,435
-7% -$4.95M 0.05% 344
2022
Q3 		$62.4M Sell
508,635
-9,500
-2% -$1.25M 0.04% 374
2022
Q2 		$68.9M Sell
518,135
-13,200
-2% -$1.8M 0.05% 371
2022
Q1 		$72.7M Buy
531,335
+66,900
+14% +$9.32M 0.04% 419
2021
Q4 		$80.4M Sell
464,435
-52,000
-10% -$7.91M 0.05% 362
2021
Q3 		$75M Sell
516,435
-27,700
-5% -$4.05M 0.05% 382
2021
Q2 		$71.8M Sell
544,135
-57,275
-10% -$7.5M 0.04% 410
2021
Q1 		$77.2M Buy
601,410
+11,900
+2% +$1.47M 0.05% 366
2020
Q4 		$70.3M Sell
589,510
-11,500
-2% -$1.4M 0.05% 362
2020
Q3 		$68.8M Sell
601,010
-7,400
-1% -$874K 0.05% 332
2020
Q2 		$69.3M Buy
608,410
+600
+0.1% +$63.6K 0.06% 321
2020
Q1 		$48.8M Buy
607,810
+108,400
+22% +$11.2M 0.05% 345
2019
Q4 		$53.3M Sell
499,410
-17,800
-3% -$1.86M 0.05% 353
2019
Q3 		$55.4M Buy
517,210
+1,180
+0.2% +$121K 0.06% 339
2019
Q2 		$52.5M Sell
516,030
-17,600
-3% -$1.69M 0.06% 346
2019
Q1 		$48M Buy
533,630
+11,900
+2% +$1.03M 0.05% 362
2018
Q4 		$43.4M Buy
521,730
+9,100
+2% +$853K 0.06% 340
2018
Q3 		$55.3M Sell
512,630
-17,400
-3% -$1.91M 0.06% 322
2018
Q2 		$58.3M Buy
530,030
+13,000
+3% +$1.35M 0.07% 307
2018
Q1 		$51.9M Sell
517,030
-58,000
-10% -$5.94M 0.06% 319
2017
Q4 		$56.6M Buy
575,030
+2,900
+0.5% +$275K 0.06% 326
2017
Q3 		$53.6M Buy
572,130
+1,600
+0.3% +$170K 0.06% 326
2017
Q2 		$63.4M Buy
570,530
+12,100
+2% +$1.28M 0.08% 281
2017
Q1 		$54.8M Buy
558,430
+105,900
+23% +$10.1M 0.07% 301
2016
Q4 		$41.6M Sell
452,530
-2,100
-0.5% -$181K 0.07% 317
2016
Q3 		$38.5M Sell
454,630
-9,700
-2% -$815K 0.06% 338
2016
Q2 		$37.8M Buy
464,330
+28,700
+7% +$2.19M 0.06% 327
2016
Q1 		$29.8M Buy
435,630
+109,500
+34% +$7.34M 0.05% 360
2015
Q4 		$23.2M Buy
326,130
+3,800
+1% +$255K 0.06% 348
2015
Q3 		$19.8M Buy
322,330
+23,100
+8% +$1.61M 0.05% 380
2015
Q2 		$21.7M Buy
299,230
+9,600
+3% +$709K 0.06% 361
2015
Q1 		$22.3M Buy
289,630
+79,300
+38% +$5.68M 0.06% 350
2014
Q4 		$14.1M Sell
210,330
-6,700
-3% -$423K 0.05% 351
2014
Q3 		$13.2M Sell
217,030
-3,400
-2% -$210K 0.05% 355
2014
Q2 		$12.9M Buy
220,430
+79,200
+56% +$4.64M 0.05% 374
2014
Q1 		$8.18M Sell
141,230
-20,700
-13% -$1.11M 0.03% 480
2013
Q4 		$8.67M Sell
161,930
-9,200
-5% -$546K 0.03% 475
2013
Q3 		$10.6M Buy
171,130
+2,800
+2% +$168K 0.04% 401
2013
Q2 		$10.2M Buy
+168,330
New +$10M 0.04% 389

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Swiss National Bank's DGX Position: Q2 2026 in Review

Swiss National Bank reduced its Quest Diagnostics (DGX) stake by 5.1% in Q2 2026, selling an estimated $3.26M and leaving 309,900 shares worth $65.7M. The position accounts for 0.03% of the portfolio, ranked #383.

Swiss National Bank first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $80.4M in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Swiss National Bank held 309,900 shares of Quest Diagnostics worth $65.7M as of Q2 2026.
  • Swiss National Bank sold 16,600 Quest Diagnostics shares in Q2 2026, an estimated $3.26M.
  • Quest Diagnostics made up 0.03% of Swiss National Bank's portfolio in Q2 2026, its #383 holding.
  • Swiss National Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Swiss National Bank's Quest Diagnostics position peaked at $80.4M in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.